Literature DB >> 16635502

Phosphorylation of the HTLV-1 matrix L-domain-containing protein by virus-associated ERK-2 kinase.

Bénédicte Hémonnot1, Dorothée Molle, Martine Bardy, Bernard Gay, Daniel Laune, Christian Devaux, Laurence Briant.   

Abstract

L-domain-containing proteins from animal retroviruses play a critical role in the recruitment of the host cell endocytic machinery that is required for retroviruses budding. We recently demonstrated that phosphorylation of the p6(gag) protein containing the L-domain of the human immunodeficiency virus type 1 regulates viral assembly and budding. Here, we investigated whether or not the L-domain-containing protein from another human retrovirus, namely the matrix protein of the human T-cell leukemia virus type 1, that contains the canonical PTAP and PPPY L-domain motifs, shares similar functional properties. We found that MA is phosphorylated at several sites. We identified one phosphorylated amino acid in the HTLV-1 MA protein as being S105, located in the close vicinity to the L-domain sequence. S105 phosphorylation was found to be mediated by the cellular kinase ERK-2 that is incorporated within HTLV-1 virus particles in an active form. Mutation of the ERK-2 target S105 residue into an alanine was found to decrease viral release and budding efficiency of the HTLV-1(ACH) molecular clone from transfected cells. Our data thus support the postulate that phosphorylation of retroviral L-domain proteins is a common feature to retroviruses that participates in the regulation of viral budding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635502     DOI: 10.1016/j.virol.2006.02.043

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Phosphorylation Requirement of Murine Leukemia Virus p12.

Authors:  Jonathon D Brzezinski; Roland Felkner; Apexa Modi; Mengdan Liu; Monica J Roth
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

2.  ALV-miRNA-p19-01 Promotes Viral Replication via Targeting Dual Specificity Phosphatase 6.

Authors:  Yiming Yan; Sheng Chen; Liqin Liao; Shuang Gao; Yanling Pang; Xinheng Zhang; Huanmin Zhang; Qingmei Xie
Journal:  Viruses       Date:  2022-04-13       Impact factor: 5.818

Review 3.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

Review 4.  Cellular kinases incorporated into HIV-1 particles: passive or active passengers?

Authors:  Charline Giroud; Nathalie Chazal; Laurence Briant
Journal:  Retrovirology       Date:  2011-09-02       Impact factor: 4.602

Review 5.  Post-Translational Modifications of Retroviral HIV-1 Gag Precursors: An Overview of Their Biological Role.

Authors:  Charlotte Bussienne; Roland Marquet; Jean-Christophe Paillart; Serena Bernacchi
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

6.  Influence of calcium/calmodulin on budding of Ebola VLPs: implications for the involvement of the Ras/Raf/MEK/ERK pathway.

Authors:  Ziying Han; Ronald N Harty
Journal:  Virus Genes       Date:  2007-06-15       Impact factor: 2.332

7.  Identifying protein phosphorylation sites with kinase substrate specificity on human viruses.

Authors:  Neil Arvin Bretaña; Cheng-Tsung Lu; Chiu-Yun Chiang; Min-Gang Su; Kai-Yao Huang; Tzong-Yi Lee; Shun-Long Weng
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1.

Authors:  Ayumi Kudoh; Kei Miyakawa; Satoko Matsunaga; Yuki Matsushima; Isao Kosugi; Hirokazu Kimura; Satoshi Hayakawa; Tatsuya Sawasaki; Akihide Ryo
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.